comparison of pet-ct and mri for the detection of bone marrow invasion in patients with squamous...

Upload: yasser-gaber

Post on 02-Jun-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    1/8

    Comparison of PET/CT and MRI for the detection of bone marrow invasion in

    patients with squamous cell carcinoma of the oral cavity

    Yasser G. Abd El-Hafez a,b, Chien-Cheng Chen c, Shu-Hang Ng c, Chien-Yu Lin d, Hung-Ming Wang e,Sheng-Chieh Chan a, I-How Chen f, Shiang-Fu Huan f, Chung-Jan Kang f, Li-Yu Lee g, Chih-Hung Lin h,Chun-Ta Liao f,, Tzu-Chen Yen a,

    a Nuclear Medicine Department, Molecular Imaging Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROCb Radiotherapy and Nuclear Medicine Department, South Egypt Cancer Institute, Assiut University, Egyptc Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROCd Department of Radiation Oncology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROCe Department of Medical Oncology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROCfDepartment of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROCg Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROCh Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROC

    a r t i c l e i n f o

    Article history:

    Received 24 December 2010

    Received in revised form 11 February 2011

    Accepted 11 February 2011

    Keywords:

    Bone invasionOral cancer

    Mandible

    Maxilla

    Squamous cell carcinoma

    Positron emission tomography (PET)/

    computed tomography (CT)

    Fluorodeoxyglucose

    Magnetic resonance imaging

    s u m m a r y

    Our aim was to retrospectively assess the diagnostic performance from combined positron emission

    tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) for the detection

    of bone marrow invasion of the mandible or maxilla in patients with oral cavity squamous cell carcinoma

    (OCSCC).

    A total of 114 patients with OCSCC, arising from or abutting the upper or lower alveolar ridge, under-

    went staging PET/CT and MRI studies before surgery. The possibility of bone marrow invasion on PET/CT

    and MRI was graded retrospectively on a 5-point score. Histopathology was taken as the reference stan-

    dard. Sensitivity, specificity, predictive values and likelihood ratios were calculated. Clinical factorsaffecting the performance, like tumor origin and dentate status were also explored.

    PET/CT was found to be more specific than MRI (83% vs.61%, respectively,p= 0.0015) but less sensitive

    (78% vs. 97%, respectively, p = 0.0391). Dentate status and tumor origin affected the diagnostic perfor-

    mance of PET/CT. In patients with positive MRI, sensitivity and specificity of PET/CT were 78% and

    100% in dentate patients with alveolar ridge tumors, 75% and 80% in dentate patient with buccal tumors,

    90% and 33% in edentulous patients with alveolar ridge tumors and 0% and 63% for edentulous patients

    with buccal tumors, respectively.

    PET/CT is more specific than MRI and can be used to complement the role of MRI. A negative MRI result

    can confidently exclude the presence of bone marrow invasion, while in patients with positive MRI find-

    ings, a negative PET/CT may be useful to rule out bone marrow invasion in dentate patients.

    2011 Elsevier Ltd. All rights reserved.

    Introduction

    The preoperative detection of bone marrow invasion involving

    both the maxilla and mandible in patients with squamous cell

    carcinoma of the oral cavity (OCSCC) is critical to the planning of

    surgery and postoperative management. It is accepted that when

    the mandibular bone marrow is free of tumor, mandibular continu-

    ity can usually be preserved and a marginal mandibulectomy may

    be oncologically sufficient for minimal cortical erosion.1,2 However,

    once bone marrow invasion has occurred, a much more extensive

    and lengthy operation involving segmental mandibulectomy plus

    bone reconstruction is necessary to provide an adequate clear bony

    margin.3,4 When tumor invades the maxillary marrow spaces,

    greater resection margin and extensive reconstruction may be

    required.

    Computed tomography (CT) and magnetic resonance imaging

    (MRI) are the standard modalities used to evaluate primary tumor

    status in patients with OCSCC. In general, MRIispreferred because

    of its superior soft-tissue contrast resolution,5 but its diagnostic

    accuracyin the detection of bone marrow invasion is still a matter

    of debate.611 Indeed, few past studies have shown high sensitivity

    1368-8375/$ - see front matter 2011 Elsevier Ltd. All rights reserved.doi:10.1016/j.oraloncology.2011.02.010

    Corresponding authors. Address: Department of Otorhinolaryngology, Head and

    Neck Surgery, Head and Neck Oncology Group, Chang Gung Memorial Hospital,

    Chang Gung University, 5 Fu-Hsin Street, Gweishan, Taoyuan 333, Taiwan, ROC.

    Tel.: +886 3 328 1200x8466; fax: +886 3 211 0052 (C.-T. Liao). Department of

    Nuclear Medicine, Molecular Imaging Center, Chang Gung Memorial Hospital,

    Chang Gung University, 5 Fu-Hsin Street, Gweishan, Taoyuan 333, Taiwan, ROC.

    Tel.: +886 3 328 1200x2744; fax: +886 3 211 0052 (T.-C. Yen).

    E-mail addresses: [email protected] (C.-T. Liao), [email protected].

    org.tw(T.-C. Yen).

    Oral Oncology 47 (2011) 288295

    Contents lists available at ScienceDirect

    Oral Oncology

    j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / o r a l o n c o l o g y

    http://dx.doi.org/10.1016/j.oraloncology.2011.02.010mailto:[email protected]:[email protected].%20org.twmailto:[email protected].%20org.twhttp://dx.doi.org/10.1016/j.oraloncology.2011.02.010http://www.sciencedirect.com/science/journal/13688375http://www.elsevier.com/locate/oraloncologyhttp://www.elsevier.com/locate/oraloncologyhttp://www.sciencedirect.com/science/journal/13688375http://dx.doi.org/10.1016/j.oraloncology.2011.02.010mailto:[email protected].%20org.twmailto:[email protected].%20org.twmailto:[email protected]://dx.doi.org/10.1016/j.oraloncology.2011.02.010
  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    2/8

    and specificity,10,11 whereas others demonstrated high sensitivity

    but low specificity.69

    The preoperative detection of bone marrow invasion may be

    theoretically enhanced with the use of combined positron emission

    tomography (PET)/CT imaging that detects metabolic anomalies

    via differences in tissue glucose uptake. However, relatively few

    studies have addressed this question.1215 The purpose of our study

    was therefore to assess and compare the diagnostic accuracy of

    PET/CT and MRI in detecting bone marrow invasion involving both

    the maxilla and mandible in patients with OCSCC and also to ex-

    plore possible clinical factors, which might affect the performance

    of these modalities.

    Materials and methods

    Patients

    This retrospective study was approved by the Institutional

    Review Board at our hospital, and all patients provided written in-

    formed consent. The study population consisted of 114 patients

    with newly diagnosed OCSCC who were referred to our hospital

    between June 2006 and December 2009. Inclusion criteria were a

    diagnosis of SCC, originating from the alveolar ridge (upper or low-

    er) or other oral cavity subsites but involving the alveolar ridge,

    preoperative PET/CT and MRI staging studies and surgical manage-ment. All patients underwent marginal or segmental mandibulec-

    tomy, either with or without inferior maxillectomy. Segmental

    mandibulectomy was performed in the presence of: (a) bone mar-

    row invasion detected by conventional modalities (CT/MRI and

    orthopantogram); (b) an edentulous atrophic mandible; and (c) tu-

    mors close to the mandible precluding a marginal resection. Tumor

    margins were sent for frozen section. If frozen section margins

    were positive, additional tissue was excised and sent for frozen

    section in order to ensure that margins were tumor-free. The sur-

    gical defects were repaired with primary closure or reconstructed

    by free or local flaps. Patients were classified as edentulous if they

    lost one or more tooth at the site of the tumor, either the upper or

    lower alveolar ridge, as seen in the immediate post-surgical

    specimens.

    Histopathology

    The surgical specimens were fixed in 10% formalin solution and

    decalcified for a period of one day. Specimens were inked and soft

    tissue was removed to grossly evaluate the bone. In the presence

    of gross bone invasion, a representative 5 mm section of the

    bonetumor interface was prepared. In the absence of gross inva-

    sion, 2 sections (5 mm each) were taken from the site with the

    deepest tumor invasion. All sections were H&E stained in 5 lm

    thickness and reviewed by a single pathologist who was aware of

    the clinical staging.

    Table 1

    General characteristics of the study participants.

    Parameter n %

    Sex

    Male 2 (1.8)

    Female 112 (98.2)

    Age, years

    Median (range)a 50 (2977)

    Anatomical subsites

    Tongue 6 (5.3)

    Floor of the mouth 6 (5.3)

    Buccal 47 (41.2)

    Alveolar ridge 39 (34.2)

    Hard palate 2 (1.8)

    Retromolar trigone 14 (12.3)

    Dentate status

    Dentate 64 (56.1)

    Edentulous 50 (43.9)

    Metal-related artifacts

    No 53 (46.5)

    Yes 61 (53.5)

    Clinical T-status

    T1 3 (2.6)

    T2 34 (29.8)

    T3 15 (13.2)

    T4 62 (54.4)

    Pathological T-status

    T1 3 (2.6)

    T2 38 (33.3)

    T3 14 (12.3)

    T4 59 (51.8)

    Pathological bone marrow invasion

    No 77 (67.5)

    Yes 37 (32.5)

    Site of marrow invasion

    Mandible 34 (29.8)

    Maxilla 2 (1.8)

    Both 1 (0.9)

    Bone management

    MMb 16 (14)

    SMc 36 (31.6)

    MM+ MXd 36 (31.6)

    SM + MX 26 (22.8)

    a The numbers in parentheses indicate the range of the data. Unless otherwise

    indicated, values are given as numbers of patients (percentages in parentheses).b Marginal mandibulectomy.c Segmental mandibulectomy.d Maxillectomy.

    Table 2

    Diagnostic performances of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity.

    Imaging modality FNa TPb TNc FPd Total Sensitivity

    (95% CIe)

    Specificity

    (95% CIe)

    PPVf

    (95% CIe)

    NPVg

    (95% CIe)

    Accuracy

    (95% CIe)

    LR+h

    (95% CIe)

    LRi (95% CIe)

    PET/CT 8 29 64 13 114 78 (7186) 83 (7690) 69 (6178) 89 (8395) 82 (7489) 4.6 (0.88.5) 0.3 (0.71.2)

    MRI 1 36 46 29 112j 97 (94100) 61 (5270) 55 (4665) 98 (95101) 73 (6581) 2.5 (0.4 to 5.4) 0.0 (0.3 to 0.4)

    a False negative.b True positive.c True negative.d False positive.e Confidence interval.f Positive predictive value.

    g Negative predictive value.h Positive likelihood ratio.i

    Negative likelihood ratio.j Two cases had severe metal artifacts and could not be interpreted on MRI.

    Y.G. Abd El-Hafez et al./ Oral Oncology 47 (2011) 288295 289

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    3/8

    PET/CT imaging

    Patients were asked to fast for at least 6 h before the start of

    the PET study. Serum glucose level was determined at the time

    of intravenous injection of 370 MBq (10 mCi) of 18F-FDG and all

    the patients had glucose concentrations 4.8 23 5 10 6 2 67 (4786) 75 (5793) 2.7 (3.9 to 9.3)

    SUV of the primary tumor

    613.43 30 2 12 12 4 86 (7398) 0.3284 75 (6090) 0.3934 3.4 (3.1 to 9.9)

    >13.43 35 6 16 8 5 73 (5887) 62 (4578) 1.9 (2.6 to 6.4)

    Patient groupsg

    Dentate alveolar ridge 8 1 4 3 0 80 (52108) 0.0025* 100 0.1165 #i

    Dentate buccal 10 1 3 4 2 75 (48102) 0.0027* 67 (3796) 1.0000 2.3 (6.9 to 11.4)

    Edentulous alveolar ridge 25 2 18 2 3 90 (78102)

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    4/8

    Healthcare, Erlangen, Germany) MRI scanner. The MRI examina-

    tions were performed using a head-and-neck synergic coil to cover

    the entire neck fromthe skull base to the thoracic inlet. T2- and T1-

    weighted fast/turbo spinecho sequences were applied in the axial

    plane. Post gadolinium contrast enhanced T1-weighted fast/turbo

    spinecho sequences with fat saturation were applied in the axial,

    coronal, and sagittal planes at 4-mm slice thickness. All data were

    archived in DICOM format and transferred to a stand-alone work-

    station for processing. All of the imaging analysis was performed

    on a picture archiving and communication system (PACS) worksta-

    tion (Centricity 1.0; GE Healthcare, Milwaukee, WI, USA). Tumor

    invasion into the bone marrow was diagnosed by replacement of

    the marrow fat of the involved mandible or maxilla by contiguous

    tumors with abnormal T1 hypointensity, T2 hyperintensity, and

    definite contrast enhancement. Bone erosion was considered to

    be present if there was any irregular bone thinning while bone

    destruction was diagnosed in the presence of complete cortical

    bone loss. MR image distortions or artifacts close to the maxilla

    or mandible were carefully recorded.

    Image interpretation

    PET/CT images were reviewed by one nuclear physician (6 years

    experience in general nuclear medicine, 2 years in PET/CT) and one

    head-and-neck radiologist (20 years experience), and a consensus

    was reached via joint reevaluation of the images. All MRI data were

    read by an independent head-and-neck radiologist (7 years experi-

    ence), who was blinded to PET/CT findings. The readers were aware

    of tumor origin and side. The images were evaluated qualitatively

    for the presence of bone marrow invasion on a 5-point score, in

    which a score of 0 indicated that bone marrow invasion was defi-

    nitely absent; a score of 1, bone marrow invasion was probably ab-

    sent; a score of 2, ambiguous cases characterized by cortical bone

    erosion in the absence of overt bone destruction; a score of 3, bone

    marrow invasion was probably present; and a score of 4, bone

    marrow invasion was definitely present. A score of 2 or less was

    considered negative. SUV was not considered in the image

    interpretation.

    Statistical analysis

    Receiver operating characteristic (ROC) curve analysis was per-

    formed to assess discriminative power of PET/CT and MRI for bone

    marrow invasion. Histopathology was taken as the reference stan-

    dard; sensitivity, specificity, predictive values and likelihood ratios

    were calculated for expressing test performance. Categorical data

    and paired readings were analyzed using the Chi-squared (v2) test

    and the McNemars test, respectively. We determined the optimalcutoff values for tumor size and maximum SUV by ROC analysis

    based on the presence of bone marrow invasion. SUVmax was

    compared in two sub-groups using Students t-test for independent

    samples. All statistical analyses were two-sided and the signifi-

    cance level was fixed at 0.05.

    Table 5

    False-negative and false-positive results of PET/CT for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity.

    No. Anatomical

    subsite

    Dental

    status

    Metal-

    related

    artifacts

    Differentiation cTa pTb Tumor

    size

    (cm)

    SUVc

    primary

    tumor

    Bone

    management

    Marrow

    invasion

    PET/CT

    score

    PET/CT

    result

    MRI

    score

    MRI

    result

    1 ARd

    Dentate + MDf

    T4 T4 3.5 8.1 SMi

    + 2 FNl

    4 TPn

    2 Buccal Edentulous + MDf T4 T4 5 33.4 SMi + MXj + 2 FNl 4 TPn

    3 ARd Edentulous + MDf T4 T4 3.2 16.9 SMi + 0 FNl 4 TPn

    4 Buccal Edentulous + WDg T4 T4 9 10.7 SMi + MXj + 2 FNl 4 TPn

    5 Buccal Edentulous + PDh T4 T4 6 16.8 SMi + MXj + 2 FNl 4 TPn

    6 B uccal Dentate MDf T4 T4 5.2 13.5 SMi + MXj + 2 FNl 4 TPn

    7 ARd Edentulous MDf T4 T4 2.8 25.3 SMi + 0 FNl 4 TPn

    8 RMTe Dentate MDf T4 T4 5.3 20.9 SMi + 0 FNl 4 TPn

    9 RMTe Edentulous WDg T4 T4 3.5 14.3 SMi + MXj 4 FPm 4 FPm

    10 Buccal Edentulous + MDf T4 T4 4.8 12.6 MMk + MXj 4 FPm 4 FPm

    11 AR d Edentulous + MDf T4 T3 5 12.6 SMi 4 FPm 4 FPm

    12 Buccal Edentulous + MDf T4 T4 4.2 20.2 SMi 3 FPm 4 FPm

    13 Buccal Edentulous MDf T4 T4 6.5 22 SMi + MXj 3 FPm 4 FPm

    14 Buccal Dentate + MDf T4 T4 4.5 13.2 MMk + MXj 4 FPm 4 FPm

    15 Buccal Dentate + WDg T4 T3 4.5 11.3 MMk + MXj 3 FPm 4 FPm

    16 AR d Edentulous WDg T4 T3 3.8 19.8 SMi + MXj 3 FPm 4 FPm

    17 AR d Edentulous + PDh T4 T2 2.5 14.6 MMk + MXj 4 FPm 4 FPm

    18 Buccal Dentate + WDg T2 T2 3.5 23.4 MMk + MXj 4 FPm 2 TNo

    19 AR d Edentulous + WDg T2 T2 2.3 10.3 MMk 3 FPm 2 TNo

    20 AR d Edentulous + PDh T3 T3 5 4.4 SMi + MXj 4 FPm 2 TNo

    21 Buccal Edentulous MDf T2 T2 3.5 22.3 MMk + MXj 3 FPm 1 TNo

    a Clinical tumor status.b Pathological tumor status.c Standardized uptake value.d Alveolar ridge.e Retromolar trigone.f Moderately differentiated.

    g Well differentiated.h Poorly differentiated.i Segmental mandibulectomy.

    j Maxillectomy.k Marginal mandibulectomy.l False negative.

    m False positive.n

    True positive.o True negative.

    Y.G. Abd El-Hafez et al./ Oral Oncology 47 (2011) 288295 291

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    5/8

    Results

    General characteristics

    One hundred fourteen patients with squamous cell carcinoma

    of the oral cavity were enrolled (Table 1). The median time interval

    between diagnostic studies (PET/CT and MRI) and surgery was

    2 days (range: 121 days for PET/CT; 156 days for MRI). The twostudies (PET/CT and MRI) were done within 4 weeks of each other,

    except for one patient, who underwent MRI 54 days before PET/CT.

    Histopathological examination revealed the presence of marrow

    invasion in 37 patients (32.5%). More than 85% of the patients

    had the habits of cigarette smoking and betel quid chewing. The

    predominant tumor origins were buccal mucosa (41.2%) and alve-

    olar ridge (34.2%).

    Sixty-one patients had metal-related artifacts; in two of them,

    the MRI was severely distorted and uninterpretable. These two pa-

    tients were excluded from any subsequent comparative analyses.

    The presence of metal artifacts did not affect the performance of

    PET/CT. However, we encountered a single false negative result

    due to misregistration between PET and CT. The FDG activity

    seemed to be displaced by a fewmillimeters from the site of CT-de-

    tected cortical erosion (scored 2 by consensus).

    Diagnostic performance

    MRI showed the highest sensitivity and negative predictive val-

    ues (97% and 98%, respectively) with only one false negative result

    (Table 2). However, low specificity and positive predictive valueswere encountered (61% and 55%, respectively). Twenty-nine false-

    positive results were seen. Sensitivity and specificity of PET/CT

    were 78% and 83% respectively with 8 false negative and 13 false-

    positive results. Combined PET/CT was significantly more specific

    (83%vs. 61%, p = 0.0015) and less sensitive than MRI (78%vs. 97%,

    p= 0.0391). The overall accuracy was comparable (Table 3).

    Clinical factors affecting PET/CT performance

    Tumor origin and dentate status were found to affect the diag-

    nostic performance of PET/CT. Bone marrow invasion was signifi-

    cantly higher in edentulous patients than in dentate patients (23/

    50 vs. 14/64, p= 0.009). In dentate patients, PET/CT had higher

    Figure 1 Imaging findings of a 56-year-old man with a diagnosis of squamous cell carcinoma of the left buccal mucosa, (A) coronal fused PET/CT image of the tumor mass

    without FDG uptake within the marrow cavity of the mandible. The corresponding non-contrast-enhanced CT image (B) demonstrated the presence of cortical bone erosion

    only. Post gadolinium contrast enhancement coronal T2 (C) and T1 (D) MR weighted images showed a left buccal-gum cancer, with hyperintensity and enhancement in thebone marrow of left mandible, suggesting bone marrow invasion. Pathological results were positive for marrow invasion.

    292 Y.G. Abd El-Hafez et al. / Oral Oncology 47 (2011) 288295

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    6/8

    specificity (94% vs. 63%, p= 0.0001) and positive likelihood ratio

    ([LR+], 13.1 vs. 2.1). A total of 13 false-positive results were

    encountered, 10 of them were seen in edentulous patients. Inter-

    estingly, all the false-positive results were in patients who had

    the habit of betel quid chewing.

    Alveolar ridge and buccal mucosa represented the two major

    tumor origins in our study (n= 39 and 47, respectively). Tumorsoriginating in the alveolar ridge were significantly associated with

    more bone marrow invasion (25/39vs. 7/47,p< 0.0001). Consider-

    ing only these two subsites, PET/CT offered significant advantages

    in terms of sensitivity (88% vs.43%,p< 0.0001) and positive predic-

    tive value (81% vs. 30%, p < 0.0001) in alveolar ridge tumors com-

    pared with buccal tumors.

    There was a trend toward higher sensitivity, specificity, and LR+

    when the size of the tumors was less than 4.8 cm or the SUV values

    less than 13.43 mg/mL.

    MRI was positive in 65 patients; 29 of them were falsely posi-

    tive. Given this high false positive rate, we tried to identify a sub-

    group of patients with MRI-positive findings in whom PET/CT may

    be useful (Table 4). Among these 65 patients, MRI gave false-posi-

    tive results in 53.6% of dentate patients (15/28). PET/CT success-fully excluded the presence of bone marrow invasion in 13 of

    these 15 cases. In alveolar ridge tumors (n = 33), PET/CT also ex-

    cluded disease in 5 out of 8 falsely positive MRI results. False-neg-

    ative and false-positive results of PET/CT for the detection of bone

    marrow invasion in this study are shown in Table 5.

    Discussion

    Assessment of facial bones invasion by OSCC is important for

    head and neck surgical oncologists before treatment planning. In

    the past, we largely relied on the findings from physical examina-

    tion plus conventional images, such as panorex X-ray, CT and/or

    MRI with unsatisfying results, especially when patients had a cer-

    tain degree of dental problems. Studies from other groups have

    shown that both PET/CT and SPECT/CT may be clinically useful,

    with varying degrees of sensitivity (58.3100%, 92%, 41.7100%,

    39.1100%) and specificity (85100%, 86%, 57.1100%, 4097.1%)

    for PET/CT, SPECT/CT, CT, and MRI, respectively.1215 In this study,

    we found a sensitivity and specificity of 78% and 83% for PET/CT,

    and 97% and 61% for MRI, respectively. Our data suggest that

    PET/CT may complement the role of MRI for diagnosing bone mar-row invasion in patients with oral cavity cancer. A negative MRI

    Figure 2 Imaging findings of a 41-year-old manwith a diagnosis of squamous cell carcinomaof theright buccal mucosa, (A)transaxial fused PET/CT image of thetumor mass

    that shows intense FDG uptake (SUVmax = 22.3) and it violates the bone boundary of the maxilla. The corresponding coronal non-contrast-enhanced CT image (B)

    demonstrated the presence of cortical discontinuity, and also evidence of some periodontal disease. The lesion scored 4 on PET/CT by consensus. Post gadolinium contrast

    enhancement axial T2 (C) and T1 (D) MR weighted images showed right upper gum cancer without abnormal signal intensity at right maxilla, suggestive of no bone marrow

    invasion. Pathological result was negative for marrow invasion.

    Y.G. Abd El-Hafez et al./ Oral Oncology 47 (2011) 288295 293

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    7/8

    scan could confidently exclude the presence of marrow invasion in

    patients with OCSCC. However, positive results obtained with this

    modality cannot always be considered true positive and PET/CT

    scan may help to make the diagnosis. We encountered a single

    false negative MRI result. Our findings concerning the high nega-

    tive predictive value of MRI were well in line with the results of

    previous studies.611

    In our experience, there are two possible reasons to explain the

    higher false-positive results. First, Taiwan is an endemic area for

    betel quid chewing, and oral cancers in association with trismus

    with subsequent poor oral hygiene are commonly seen in clinical

    practice.16,17 Betel quid chewing was observed in 87% of patients

    in this study. There were 28 false-positive results out of 99 patients

    chewing betel quid compared to 1/15 patients not having this habit

    (positive predictive value = 51%vs. 88%, p = 0.02). Second, all the

    studied tumors were involving the alveolar ridge, which could eli-

    cit a local inflammatory response. It has been reported that MRI

    may yield falsely positive results in inflammatory odontogenic

    disease.18

    We encountered 8 false-negative PET/CT findings (Table 5); in 4

    of them, the non-optimized CT intended for AC/AL was unable to

    detect sites of minimal bone breakthrough. We assume that a more

    optimized CT protocol for the head and neck region may add to the

    diagnostic yield of PET/CT. The other 4 false-negative PET/CT

    results were either due to low tracer uptake in the bone marrow

    (patients # 1 and # 6), misregistration of the CT and PET images

    (Patient # 5) or retraction of the edentulous alveolar ridge (Patient

    # 2), which mislead the localization of FDG uptake ( Fig. 1). PET/CT

    showed significantly higher false positive rate in edentulous com-

    pared to dentate patients (37% vs. 6%, p= 0.0001). The reason for

    that may be explained by: (a) Repeated episodes of periodontitis

    are common in edentulous patients which may show avidity to

    FDG (Fig. 2).19 (b) The mean SUV of the primary tumor was signif-

    icantly higher in edentulous compared to dentate patients (15.2 vs.

    12.6,p

    = 0.036). High FDG uptake may produce a spillover effect,

    leading to overestimation of the exact tumor extension (Fig. 3).20

    In this study, the sensitivity and positive predictive value of

    PET/CT were significantly lower for buccal compared to alveolar

    ridge tumors; however, the negative predictive value, LR+ and

    overall accuracy remained comparable. Of note, among all the

    false-positive results encountered by PET/CT, the mean SUV within

    buccal tumors was higher, though not significantly, than that seen

    in alveolar ridge tumors (17.8vs. 12.3,p = 0.1).

    Our study is not without important limitations. A head and neck

    PET/CT study was not performed in all participants following the

    whole-body acquisition. No contrast media were used routinely

    for the CT portion of PET/CT. Moreover, the CT portion of PET/CT

    was not optimized for diagnostic purpose. In addition, the inevita-

    ble partial volume effect in PET/CT should be considered. Finally,

    this study is a retrospective single-reader analysis, which reflects

    a single center experience. Strengths of our report include the large

    sample size, the use of histopathological examination as the gold

    standard for comparison, and the homogeneity of diagnosis and

    treatment plans.

    Figure 3 Imaging findings of a 43-year-old man with a diagnosis of squamous cell carcinoma of the right buccal mucosa, (A) coronal fused PET/CT image of the tumor mass

    that shows intense FDG uptake (SUVmax = 22) and it violates the bone boundary of the mandible. The corresponding coronal non-contrast-enhanced CT image (B)

    demonstrated the presence of cortical erosion in the edentulous alveolar socket and possible breakthrough. Post gadolinium contrast enhancement coronal T2 (C) and T1 (D)

    MR weighted images showed right buccal-gum cancer with mild bone erosion on the edentate alveolar socket. No abnormal signal intensity at right mandible, indicatingbone cortex invasion without bone marrow involvement. Pathological result was positive for both periosteal and cortical invasion but negative for marrow invasion.

    294 Y.G. Abd El-Hafez et al. / Oral Oncology 47 (2011) 288295

  • 8/11/2019 Comparison of PET-CT and MRI for the Detection of Bone Marrow Invasion in Patients With Squamous Cell Carcino

    8/8

    Conclusion

    PET/CT is more specific than MRI and can be used to comple-

    ment the role of MRI. A negative MRI result can confidently exclude

    the presence of bone marrow invasion in patients with squamous

    cell carcinomas of the oral cavity. In dentate patients with positive

    MRI findings, a negative PET/CT may be useful to rule out bone

    marrow invasion in dentate patients. PET/CT had a significantlyhigher sensitivity and positive predictive value in alveolar ridge tu-

    mors compared to buccal mucosa tumors.

    Conflict of Interest

    None declared.

    Acknowledgements

    This work was supported in part by a Grant-in-Aid for FDG PET

    Research in Oral Cancer from Chang Gung Memorial Hospital-Link-

    ou (CMRPG370062).

    References

    1. Barttelbort SW, Bahn SL, Ariyan SA. Rim mandibulectomy for cancer of the oral

    cavity.Am J Surg1987;154(4):4238.2. Ord RA, Sarmadi M, Papadimitrou J. A comparison of segmental and marginal

    bony resection for oral squamous cell carcinoma involving the mandible. J OralMaxillofac Surg1997;55(5):4707. discussion 78.

    3. Politi M, Costa F, Robiony M, Rinaldo A, Ferlito A. Review of segmental and

    marginal resection of the mandible in patients with oral cancer. ActaOtolaryngol 2000;120(5):56979.

    4. Wax MK, Bascom DA, Myers LL. Marginal mandibulectomy vs segmental

    mandibulectomy: indications and controversies. Arch Otolaryngol Head NeckSurg2002;128(5):6003.

    5. Ahmad A, Branstetter BF. CT versus MR: still a tough decision.Otolaryngol ClinNorth Am2008;41(1):122.

    6. Rajesh A, Khan A, Kendall C, Hayter J, Cherryman G. Can magnetic resonance

    imaging replace single photon computed tomography and computed

    tomography in detecting bony invasion in patients with oral squamous cell

    carcinoma?Br J Oral Maxillofac Surg2008;46(1):114.

    7. Tsue TT, McCulloch TM, Girod DA, Couper DJ, Weymuller Jr EA, Glenn MG.

    Predictors of carcinomatous invasion of the mandible. Head Neck1994;16(2):11626.

    8. Van Cann EM, Koole R, Oyen WJ, de Rooy JW, de Wilde PC, Slootweg PJ, et al.

    Assessment of mandibular invasion of squamous cell carcinoma by various

    modes of imaging: constructing a diagnostic algorithm. Int J Oral Maxillofac Surg2008;37(6):53541.

    9. van den Brekel MW, Runne RW, Smeele LE, Tiwari RM, Snow GB, Castelijns JA.

    Assessment of tumour invasion into the mandible: the value of different

    imaging techniques. Eur Radiol 1998;8(9):15527.

    10. Bolzoni A, Cappiello J, Piazza C, Peretti G, Maroldi R, Farina D, et al. Diagnosticaccuracy of magnetic resonance imaging in the assessment of mandibular

    involvement in oral-oropharyngeal squamous cell carcinoma: a prospective

    study.Arch Otolaryngol Head Neck Surg2004;130(7):83743.11. Vidiri A, Guerrisi A, Pellini R, Manciocco V, Covello R, Mattioni O, et al. Multi-

    detector row computed tomography (MDCT) and magnetic resonance imaging

    (MRI) in the evaluation of the mandibular invasion by squamous cell

    carcinomas (SCC) of the oral cavity. Correlation with pathological data. J ExpClin Cancer Res 2010;29:73.

    12. Babin E, Desmonts C, Hamon M, Benateau H, Hitier M. PET/CT for assessing

    mandibular invasion by intraoral squamous cell carcinomas. Clin Otolaryngol2008;33(1):4751.

    13. Goerres GW, Schmid DT, Schuknecht B, Eyrich GK. Bone invasion in patients

    with oral cavitycancer: comparison of conventionalCT with PET/CT andSPECT/

    CT.Radiology 2005;237(1):2817.14. Gu DH, Yoon DY, Park CH, Chang SK, Lim KJ, Seo YL, et al. CT, MR, (18)F-FDG

    PET/CT, and their combined use for the assessment of mandibular invasion

    by squamous cell carcinomas of the oral cavity. Acta Radiol 2010;51(10):11119.

    15. Pentenero M, Cistaro A, Brusa M, Ferraris MM, Pezzuto C, Carnino R, et al.

    Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. HeadNeck2008;30(11):148896.

    16. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Analysis of risk

    factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol2008;15(3):91522.

    17. Lin CY, Wang HM, Kang CJ, Lee LY, Huang SF, Fan KH, et al. Primary tumor site

    as a predictor of treatment outcome for definitive radiotherapy of advanced-

    stage oral cavity cancers. Int J Radiat Oncol Biol Phys 2010;78(4):10119.18. Imaizumi A, Yoshino N, Yamada I, Nagumo K, Amagasa T, Omura K, et al. A

    potential pitfall of MR imaging for assessing mandibular invasion of squamous

    cell carcinoma in the oral cavity. Am J Neuroradiol 2006;27(1):11422.19. ShimamotoH, Tatsumi M, Kakimoto N, HamadaS, Shimosegawa E, Murakami S,

    et al. (18)F-FDG accumulation in the oral cavity is associated with periodontal

    disease and apical periodontitis: an initial demonstration on PET/CT. Ann NuclMed2008;22(7):58793.

    20. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging.JNucl Med2007;48(6):93245.

    Y.G. Abd El-Hafez et al./ Oral Oncology 47 (2011) 288295 295